G
Genomic Health
Biotech & Life Sciences · Redwood City, United States · Founded 2000 · IPO 2005
Genomic Health mafia
Startups founded by Genomic Health alumni
Former Genomic Health employees who went on to start their own companies. Sorted by Dealroom signal score.
David GilboaUnited States
Lisa AldersonUnited States
Randy ScottUnited States
Greg SchaferUnited StatesGlobal footprint
Where Genomic Health has talent and traffic
team presence
across markets
Talent graph
The shape of Genomic Health's talent
Dealroom maps Genomic Health's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$79M patent portfolio · 23 active families
Where Genomic Health concentrates vs peers
Each axis is a top-10 topic across Genomic Health and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Genomic Health's 4 investments and acquisitions.
Every disclosed deal where Genomic Health appeared as a backer or acquirer, 2013–2018. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Genomic Health's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Genomic Health deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Genomic Health's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Genomic Health
An AI-synthesized read of the highest-engagement posts about Genomic Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genomic Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.